Experience of Anti-Viral Therapy in Hepatitis B-Associated Membranous Nephropathy, Including Lamivudine-Resistant Strains

@inproceedings{Sun2012ExperienceOA,
  title={Experience of Anti-Viral Therapy in Hepatitis B-Associated Membranous Nephropathy, Including Lamivudine-Resistant Strains},
  author={In O. Sun and Yu Ah Hong and Hoon Suk Park and Sun Ryoung Choi and Byung Ha Chung and Cheol Whee Park and Chul Woo Yang and Yong Soo Kim and Bum Soon Choi},
  booktitle={The Korean journal of internal medicine},
  year={2012}
}
BACKGROUND/AIMS Chronic hepatitis B infection is a common cause of secondary membranous nephropathy (MN) in endemic areas. Lamivudine treatment improves renal outcome in patients with hepatitis B virus-associated MN (HBV-MN), but prolonged use leads to the emergence of lamivudine-resistant variants. We describe our experience treating lamivudine-resistant and other strains of HBV-MN with new antiviral drugs. METHODS Of the 89 patients biopsied and diagnosed with MN from 1996 to 2011, 10… CONTINUE READING
3 Citations
22 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Hepatitis B virus - related membranous nephropathy treated with entecavir

  • AS Lai, KN Lai
  • Nephrol - ogy ( Carlton )
  • 2010

Similar Papers

Loading similar papers…